Table 2.
Laboratory findings of participants in the three groups.
| T2DM (n = 80) | COVID-19 (n = 76) | T2DM + COVID-19 (n = 55) | |
|---|---|---|---|
| WBC, × 109/L | 5.7 (5.1–6.8) | 5.4 (4.7–6.4) | 6.3 (5.3–6.9) |
| Lyc, ×109/L | 2.0 (1.6–2.5) | 1.4 (1.0–1.7) # | 1.6 (1.2–2.1) # |
| CRP, mg/L | 0.7 (0.5–1.5) | 2.0 (0.9–5.8) # | 2.9 (1.4–11.9) # |
| ALT, U/L | 19 (15–30.5) | 22.3 (13.4–33.9) | 21.4 (15.6–29.8) |
| AST, U/L | 17 (14.3–24) | 20.1 (15.2–25.7) | 18.1 (13.8–22.5) |
| Albumin, g/L | 41.7 (39.3–44) | 35.4 (33–36.9)# | 36.8 (34.1–39.9)# |
| Globulin, g/L | 27.8 (25.0–30.6) | 26.1 (24.2–28.0) | 26.7 (25.0–29.3) |
| Creatinine, µmol/L | 54.4 (45.2–62.2) | 65.1 (55.0–74.8) # | 63 (55.0–70.7) # |
| BUN, mmol/L | 5.3 (4.5–6.3) | 4.6 (3.8–5.5) | 4.8 (4.6–6.0) |
| UA,μmol/L | 310 (264.5–379.5) | 253 (218.0–305.8) # | 300 (245.0–344.0) #* |
| FPG, mmol/L | 7.1 (6.2–9.2) | 4.6 (4.3–5.1) # | 7.2 (5.5–8.0) * |
| LDH, U/L | 164.5(145.3–176.8) | 214.1(184.1–269.0) # | 221.3(178.9–285.5) # |
WBC, white blood cell; Lyc, lymphocyte; CRP, C-reactive protein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; UA, uric acid; FPG, fasting plasma glucose; LDH, lactic dehydrogenase; #:P < 0.05 compared to T2DM group; *:P < 0.05 compared to COVID-19 group.